FDA Adverse Event Injury Summary report: N

VELOCITY DELIVERY MICROCATHETER

MDR report key: 4820230 · Received June 4, 2015

Report

Report Number
3005168196-2015-00574
Event Type
Injury
Date Received
June 4, 2015
Date of Event
November 18, 2015
Report Date
March 3, 2015
Manufacturer
PENUMBRA, INC.
Product Code
DQY
PMA / PMN Number
K100826
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION RECEIVED ON 07/06/2016 INDICATED THAT THE VASOSPASM OCCURRED ON (B)(6) 2015.

Additional Manufacturer Narrative · 1

CONCLUSION: VASOSPAM IS A KNOWN AND ANTICIPATED COMPLICATION WITH THESE TYPES OF PROCEDURES AND IS NOTED IN THE DEVICE LABELING. THEREFORE, IT WAS DETERMINED THAT THE REPORTED EVENT WAS AN ANTICIPATED PROCEDURAL COMPLICATION. THE MANUFACTURING RECORDS FOR THIS LOT WERE REVIEWED AND DID NOT REVEAL ANY OUTSTANDING DISCREPANCIES, DESIGN, OR QUALITY CONCERNS. THIS MDR IS ASSOCIATED WITH MDR 3005168196-2015-00575. DEVICE WAS DISPOSED OF BY HOSPITAL.

Description of Event or Problem · 1

THE PATIENT WAS UNDERGOING A THROMBECTOMY PROCEDURE USING A VELOCITY DELIVERY MICROCATHETER AND A PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER. POST PROCEDURE, THE PATIENT EXPERIENCED A MILD VASOSPASM AS A NON-SERIOUS ADVERSE EVENT AND ANEMIA AS A NON-SERIOUS ADVERSE EVENT. THE VASOSPASM EVENT WAS ADJUDICATED TO HAVE A POSSIBLE RELATIONSHIP TO THE PENUMBRA SYSTEM, PROBABLE RELATIONSHIP TO THE ANGIOGRAPHIC PROCEDURE, AND UNRELATED RELATIONSHIP TO THE INDEX STROKE. THE VASOSPASM EVENT WAS EVALUATED AS RESOLVED WITHIN THE SAME DAY. THE ANEMIA EVENT WAS ADJUDICATED WITH AN UNCERTAIN RELATIONSHIP TO THE PENUMBRA SYSTEM AND ANGIOGRAPHIC PROCEDURE, AND UNRELATED RELATIONSHIP TO THE INDEX STROKE. AT ONE-WEEK POST-OP, THE PATIENT WAS DOING WELL CLINICALLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
361608 VELOCITY DELIVERY MICROCATHETER DQY DQY PENUMBRA, INC. F45313

Patients

Seq Age Sex Outcome Treatment
1 48 YR Other